Replimune (REPL) Assets Average (2018 - 2026)
Replimune (REPL) reported Assets Average of $333.0 million for Q1 2026, down 42.34% on a YoY basis from $577.5 million in Q1 2025, and down 7.89% sequentially from $361.5 million in Q4 2025.
Replimune (REPL) Assets Average (2018 - 2026) Analysis & Trends
Replimune (REPL) has 9 years of Assets Average data on file, last reported at $333.0 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 42.34% year-over-year to $333.0 million; the trailing twelve-month figure through Mar 2026 stood at $333.0 million (down 42.34% YoY), and the FY2026 full-year result was $441.9 million, down 14.95% from the prior year.
- Assets Average retreated to $333.0 million in Q1 2026, from $361.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $662.6 million in Q1 2023 to a low of $333.0 million in Q1 2026.
- A 5-year average of $509.3 million and a median of $511.3 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average soared 40.01% in 2023 and slumped 42.34% in 2026, its largest moves.
- Tracing REPL's Assets Average over 5 years: stood at $557.3 million in 2022, then retreated by 1.73% to $547.7 million in 2023, then grew by 0.59% to $550.9 million in 2024, then slumped by 34.38% to $361.5 million in 2025, then dropped by 7.89% to $333.0 million in 2026.
- Business Quant data shows REPL's Assets Average at $333.0 million in Q1 2026, $361.5 million in Q4 2025, and $429.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 332.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 332.99 Mn |
| Dec 31, 2025 | 361.52 Mn |
| Sep 30, 2025 | 429.48 Mn |
| Jun 30, 2025 | 510.42 Mn |
| Mar 31, 2025 | 577.48 Mn |
| Dec 31, 2024 | 550.92 Mn |
| Sep 30, 2024 | 516.58 Mn |
| Jun 30, 2024 | 511.34 Mn |
| Mar 31, 2024 | 510.33 Mn |
| Dec 31, 2023 | 547.66 Mn |
| Sep 30, 2023 | 583.14 Mn |
| Jun 30, 2023 | 625.24 Mn |
| Mar 31, 2023 | 662.57 Mn |
| Dec 31, 2022 | 557.32 Mn |
| Sep 30, 2022 | 447.76 Mn |
| Jun 30, 2022 | 460.31 Mn |
| Mar 31, 2022 | 473.24 Mn |
| Dec 31, 2021 | 494.37 Mn |
| Sep 30, 2021 | 513.59 Mn |
| Jun 30, 2021 | 533.41 Mn |